Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C SWANTON

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
The EMBO Journal|February 2, 1999
Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirusD J Mann, E S Child, C Swanton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2020
Response to W.C. Taylor, and C. Fiala and E.P. DiamandisM C Liu, G R Oxnard, E A Klein, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 18, 2015
The Value of Patient and Public Involvement in Trial Design and DevelopmentS Gasson, J Bliss, M Jamal-Hanjani, et al.
Nature|November 21, 1997
Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteinsC Swanton, D J Mann, B Fleckenstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999
IFN-gamma down-regulates MHC expression and antigen processing in a human B cell lineD O'Neil, C Swanton, A Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 28, 2021
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAM C Liu, G R Oxnard, E A Klein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2014
Prioritizing targets for precision cancer medicineF Andre, E Mardis, M Salm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2018
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinicT A Chan, M Yarchoan, E Jaffee, et al.
Oral Oncology|August 30, 2000
Percutaneous endoscopic gastrostomy at the time of tumour resection in advanced oral cancerD R Cunliffe, C Swanton, C White, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastomaM A Qazi, P Vora, C Venugopal, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
The EMBO Journal|February 2, 1999
Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirusD J Mann, E S Child, C Swanton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2020
Response to W.C. Taylor, and C. Fiala and E.P. DiamandisM C Liu, G R Oxnard, E A Klein, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 18, 2015
The Value of Patient and Public Involvement in Trial Design and DevelopmentS Gasson, J Bliss, M Jamal-Hanjani, et al.
Nature|November 21, 1997
Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteinsC Swanton, D J Mann, B Fleckenstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999
IFN-gamma down-regulates MHC expression and antigen processing in a human B cell lineD O'Neil, C Swanton, A Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 28, 2021
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAM C Liu, G R Oxnard, E A Klein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2014
Prioritizing targets for precision cancer medicineF Andre, E Mardis, M Salm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2018
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinicT A Chan, M Yarchoan, E Jaffee, et al.
Oral Oncology|August 30, 2000
Percutaneous endoscopic gastrostomy at the time of tumour resection in advanced oral cancerD R Cunliffe, C Swanton, C White, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2017
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastomaM A Qazi, P Vora, C Venugopal, et al.
Pageof 7